Doherty James J. 4
4 · Acumen Pharmaceuticals, Inc. · Filed Feb 1, 2024
Insider Transaction Report
Form 4
Doherty James J.
President and CDO
Transactions
- Award
Employee Stock Option (right to buy)
2024-02-01+601,000→ 601,000 totalExercise: $3.11Exp: 2034-02-01→ Common Stock (601,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on February 1, 2025, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest and become exercisable each month thereafter, subject to Reporting Person continuing to provide service through each such date.